Recombinant monoclonal antibody of unknown specificity (isotype control) with variable regions (i.e., specificity) from the hybridoma MOPC-21. This is a re-formatted antibody created as part of a panel offering of antibodies of the same clone in different formats (species, isotype, subtype and modified versions) for use as isotype controls. Manufactured using a proprietary recombinant platform technology.